Matching-adjusted indirect comparison of bosutinib, dasatinib and nilotinib effect on survival and major cytogenetic response in treatment of second-line chronic phase chronic myeloid leukemia
- Jorge E. Cortes
- , Bogdan Muresan
- , Carla Mamolo
- , Joseph C. Cappelleri
- , Rocco J. Crescenzo
- , Yun Su
- , Carlo Gambacorti-Passerini
- , Bart Heeg
- , B. Douglas Smith
Research output: Contribution to journal › Article › peer-review
17
Link opens in a new tab
Scopus
citations